STAT3 and cancer: Therefore, development of new anti-cancer agents with less toxicity and overcoming chemotherapeutic drug resistance can be achieved by: (1) using drugs that target two or three activators of STAT324 or (2) combined targeting of STAT3 and STAT5.8